Hologic, Inc. (HOLX)

US — Healthcare Sector
Peers: COO  ICLR  MEDP  SNN  ILMN  TEM  FMS  WST  NBIX  BAX 

Automate Your Wheel Strategy on HOLX

With Tiblio's Option Bot, you can configure your own wheel strategy including HOLX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HOLX
  • Rev/Share 18.005
  • Book/Share 21.5879
  • PB 3.4278
  • Debt/Equity 0.5209
  • CurrentRatio 3.5547
  • ROIC 0.0743

 

  • MktCap 16459026868.0
  • FreeCF/Share 4.3608
  • PFCF 16.8258
  • PE 29.7959
  • Debt/Assets 0.2864
  • DivYield 0
  • ROE 0.1151

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 5
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade HOLX Evercore ISI In-line Outperform -- $78 Oct. 7, 2025
Upgrade HOLX Argus Hold Buy -- $80 Aug. 18, 2025
Upgrade HOLX RBC Capital Mkts Sector Perform Outperform -- $87 Aug. 6, 2025
Upgrade HOLX Citigroup Neutral Buy -- $80 July 9, 2025
Reiterated HOLX Needham -- Hold -- -- May 27, 2025
Downgrade HOLX Argus Buy Hold -- -- March 3, 2025
Downgrade HOLX Leerink Partners Outperform Market Perform $80 $75 Feb. 6, 2025
Downgrade HOLX Needham Buy Hold -- -- Feb. 3, 2025
Initiation HOLX Wolfe Research -- Peer Perform -- -- Dec. 13, 2024
Reiterated HOLX Needham -- Buy -- $90 Dec. 10, 2024

News

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion
BX, HOLX, TPG
Published: October 21, 2025 by: WSJ
Sentiment: Positive

Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding shares of the women's-health company for $76 apiece in cash.

Read More
image for news Blackstone, TPG to Buy Hologic for Up to $18.3 Billion
Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal
BX, HOLX, TPG
Published: October 21, 2025 by: Reuters
Sentiment: Positive

Blackstone and TPG have agreed to acquire medical diagnostics firm Hologic in an up to $18.3 billion deal, the company said on Tuesday.

Read More
image for news Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
HOLX
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral

MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #aquisition--Hologic to be Acquired by Blackstone and TPG for up to $79 per Share.

Read More
image for news Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
Billion-Dollar Buyout Buzz Boosts Medtech Stock
HOLX
Published: October 20, 2025 by: Schaeffers Research
Sentiment: Positive

Shares of Hologic Inc (NASDAQ:HOLX) are up 2.4% to trade at $71.51 at last glance, earlier tapping $73.09 their highest level since early January.

Read More
image for news Billion-Dollar Buyout Buzz Boosts Medtech Stock
Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings
HOLX
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Neutral

HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.

Read More
image for news Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
HOLX
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Read More
image for news Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
HOLX
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Positive

Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.

Read More
image for news HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
HOLX
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.

Read More
image for news Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
How to Play HOLX Stock This Breast Cancer Awareness Month?
HOLX
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive

Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.

Read More
image for news How to Play HOLX Stock This Breast Cancer Awareness Month?
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
HOLX
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.

Read More
image for news HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
HOLX vs. IDXX: Which Stock Is the Better Value Option?
HOLX, IDXX
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?

Read More
image for news HOLX vs. IDXX: Which Stock Is the Better Value Option?
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.

Read More
image for news Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
HOLX
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
HOLX
Published: September 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Read More
image for news Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Volition Signs Co-Marketing and Services Agreement with Hologic
HOLX, VNRX
Published: September 29, 2025 by: PRNewsWire
Sentiment: Neutral

HENDERSON, Nev. , Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ("Hologic") for the co-marketing of Volition's Nu.Q® Discover service.

Read More
image for news Volition Signs Co-Marketing and Services Agreement with Hologic
Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm
HOLX
Published: September 29, 2025 by: PRNewsWire
Sentiment: Neutral

HAUPPAUGE, N.Y. , Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States.

Read More
image for news Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
HOLX
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive

Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.

Read More
image for news HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
HOLX, TMO
Published: September 22, 2025 by: Zacks Investment Research
Sentiment: Positive

Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

Read More
image for news HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
HOLX
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read More
image for news Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic's Strong International Traction to Continue Despite Headwinds
HOLX
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Negative

HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.

Read More
image for news Hologic's Strong International Traction to Continue Despite Headwinds
Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock?
HOLX
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Hologic (HOLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Read More
image for news Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock?
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
HOLX
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.

Read More
image for news Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
HOLX
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX lifts its 2025 revenue and EPS outlook on Q3 strength, tariff relief, and growth across Breast Health and GYN Surgical.

Read More
image for news Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
HOLX
Published: September 09, 2025 by: Seeking Alpha
Sentiment: Neutral

Hologic, Inc. (NASDAQ:HOLX ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Stephen MacMillan - Chairman, CEO & President Conference Call Participants Kallum Titchmarsh - Morgan Stanley, Research Division Michael Matson - Needham & Company, LLC, Research Division Presentation Kallum Titchmarsh Equity Analyst Okay. Thank you, everyone.

Read More
image for news Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
HOLX
Published: September 04, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX's Panther Fusion expands its diagnostics menu, fueling assay growth and unlocking more upside in molecular testing.

Read More
image for news Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?
HOLX
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX fuels growth with targeted M&A across Diagnostics, Breast Health, and GYN Surgical, backed by a strong balance sheet.

Read More
image for news The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
HOLX
Published: August 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Read More
image for news Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
BSX, HOLX
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.

Read More
image for news HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
Here's Why Hologic (HOLX) is a Strong Value Stock
HOLX
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Here's Why Hologic (HOLX) is a Strong Value Stock
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
HOLX
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive

HOLX's Genius digital cytology system and global rollout position its Cytology unit for long-term growth despite near-term headwinds.

Read More
image for news What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?

About Hologic, Inc. (HOLX)

  • IPO Date 1990-03-01
  • Website https://www.hologic.com
  • Industry Medical - Instruments & Supplies
  • CEO Stephen P. MacMillan
  • Employees 7063

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.